-
From
Independent Advisory and Evaluation Service
-
Published on
26.11.24
We recently had the opportunity to sit down virtually with Dr. David Meyer and Dr. Glenn Bryan, key contributors to the evaluation of the CGIAR Genetic Innovation Science Group (GI SG) under the SG evaluations umbrella (visit Portal). In this Q& A, David and Glenn share their insights and key takeaways from the real-time evaluation process. Their expertise highlights the achievements and challenges of the GI SG while exploring future directions for partnerships, breeding strategies, and innovative approaches in global agriculture as part of the new CGIAR portfolio.
Key takaways
- Complex evaluation process with challenges in navigating CGIAR’s partnerships and structure.
- Partnerships with NARS and the private sector are vital to CGIAR’s success.
- Transitioning from technical to strategic perspectives highlights the need for organizational effectiveness.
- CGIAR should adopt a “seed business” mindset for end-to-end innovation and sustainability.
- Future evaluations should focus on clearer roles, communication, and field engagement.